# Mesosil

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mesosil

- Industry: Biotechnology
- Headquarters: Toronto, Canada
- Website: www.mesosil.com
- Total disclosed funding: $2.3M
- Latest round: Seed (May 1, 2024)
- Investors on record: 6

## About

Based in Ontario, Canada, and founded in 2018, Mesosil Inc. develops anti-infective biomaterials for medical devices. The company was founded by Dr. Cameron Stewart. In June 2024, Mesosil Inc. raised CAD 2.2 million in seed funding led by new investor GreenSky Ventures, with participation from returning investors Archangel Network and NorthSpring Capital Partners. New investor Greyhill Group and individual investors also participated in the round.

Mesosil Inc. develops an antimicrobial material to prevent infection at the medical device-tissue interface for infection treatment and disease prediction. The company's technology is suited for dental restoratives and dental implant surfaces with no change to clinician workflow. The company's technology utilizes antibacterial self-assembled materials that respond to the presence of pathogenic bacteria.

## Funding rounds

- Seed, May 1, 2024, $1.6M — GreenSky Ventures, NorthSpring Capital Partners, Greyhill Group, Archangel, Centre for Aging + Brain Health Innovation
- Seed, Jul 13, 2021, $0.7M — Archangel Ventures, NorthSpring Capital Partners

## Investors

- Archangel Ventures (https://capitalatlas.ai/funds/archangel-ventures) — Seed
- NorthSpring Capital Partners — Seed
- GreenSky Ventures (https://capitalatlas.ai/funds/greensky-ventures) — Seed
- Greyhill Group — Seed
- Archangel (https://capitalatlas.ai/funds/archangel) — Seed
- Centre for Aging + Brain Health Innovation — Seed